References
1. Russo GL, Tedesco I, Spagnuolo C, Russo M. Antioxidant polyphenols in
cancer treatment: Friend, foe or foil? Semin Cancer Biol. 2017;46:1-13.
2. Spagnuolo C, Moccia S, Russo GL. Anti-inflammatory effects of
flavonoids in neurodegenerative disorders. European Journal of Medicinal
Chemistry. 2018;153:105-15.
3. Ferrer JL, Austin MB, Stewart C, Jr., Noel JP. Structure and function
of enzymes involved in the biosynthesis of phenylpropanoids. Plant
Physiol Biochem. 2008;46(3):356-70.
4. Puelles VG, Lütgehetmann M, Lindenmeyer MT, Sperhake JP, Wong MN,
Allweiss L, et al. Multiorgan and Renal Tropism of SARS-CoV-2. N Engl J
Med. 2020;383(6):590-2.
5. Varga Z, Flammer AJ, Steiger P, Haberecker M, Andermatt R,
Zinkernagel AS, et al. Endothelial cell infection and endotheliitis in
COVID-19. Lancet. 2020;395(10234):1417-8.
6. Davis JM, Murphy EA, Carmichael MD. Effects of the dietary flavonoid
quercetin upon performance and health. Curr Sports Med Rep.
2009;8(4):206-13.
7. Debiaggi M, Tateo F, Pagani L, Luini M, Romero E. Effects of propolis
flavonoids on virus infectivity and replication. Microbiologica.
1990;13(3):207-13.
8. De Palma AM, Vliegen I, De Clercq E, Neyts J. Selective inhibitors of
picornavirus replication. Med Res Rev. 2008;28(6):823-84.
9. Smith M, Smith JC. Repurposing Therapeutics for COVID-19:
Supercomputer-Based Docking to the SARS-CoV-2 Viral Spike Protein and
Viral Spike Protein-Human ACE2 Interface. 2020.
10. Yi L, Li Z, Yuan K, Qu X, Chen J, Wang G, et al. Small molecules
blocking the entry of severe acute respiratory syndrome coronavirus into
host cells. J Virol. 2004;78(20):11334-9.
11. Walls AC, Park Y-J, Tortorici MA, Wall A, McGuire AT, Veesler D.
Structure, Function, and Antigenicity of the SARS-CoV-2 Spike
Glycoprotein. Cell. 2020;181(2):281-92.e6.
12. Zhang DH, Wu KL, Zhang X, Deng SQ, Peng B. In silico screening of
Chinese herbal medicines with the potential to directly inhibit 2019
novel coronavirus. J Integr Med. 2020;18(2):152-8.
13. Manach C, Mazur A, Scalbert A. Polyphenols and prevention of
cardiovascular diseases. Curr Opin Lipidol. 2005;16(1):77-84.
14. Graefe EU, Derendorf H, Veit M. Pharmacokinetics and bioavailability
of the flavonol quercetin in humans. Int J Clin Pharmacol Ther.
1999;37(5):219-33.
15. Harwood M, Danielewska-Nikiel B, Borzelleca JF, Flamm GW, Williams
GM, Lines TC. A critical review of the data related to the safety of
quercetin and lack of evidence of in vivo toxicity, including lack of
genotoxic/carcinogenic properties. Food Chem Toxicol.
2007;45(11):2179-205.
16. Ali MY, Seong SH, Jung HA, Choi JS. Angiotensin-I-Converting Enzyme
Inhibitory Activity of Coumarins from Angelica decursiva. Molecules
(Basel, Switzerland). 2019;24(21):3937.
17. Moon YJ, Wang L, DiCenzo R, Morris ME. Quercetin pharmacokinetics in
humans. Biopharm Drug Dispos. 2008;29(4):205-17.
18. Awad HM, Boersma MG, Boeren S, Van Bladeren PJ, Vervoort J, Rietjens
IM. Quenching of quercetin quinone/quinone methides by different
thiolate scavengers: stability and reversibility of conjugate formation.
Chem Res Toxicol. 2003;16(7):822-31.
19. Boots AW, Kubben N, Haenen GR, Bast A. Oxidized quercetin reacts
with thiols rather than with ascorbate: implication for quercetin
supplementation. Biochem Biophys Res Commun. 2003;308(3):560-5.
20. Bors W, Michel C, Schikora S. Interaction of flavonoids with
ascorbate and determination of their univalent redox potentials: a pulse
radiolysis study. Free Radic Biol Med. 1995;19(1):45-52.
21. Boots AW, Li H, Schins RP, Duffin R, Heemskerk JW, Bast A, et al.
The quercetin paradox. Toxicol Appl Pharmacol. 2007;222(1):89-96.
22. Pavan R, Jain S, Shraddha, Kumar A. Properties and therapeutic
application of bromelain: a review. Biotechnol Res Int.
2012;2012:976203-.
23. Labò N, Ohnuki H, Tosato G. Vasculopathy and Coagulopathy Associated
with SARS-CoV-2 Infection. Cells. 2020;9(7).
24. Bindoli A, Valente M, Cavallini L. Inhibitory action of quercetin on
xanthine oxidase and xanthine dehydrogenase activity. Pharmacol Res
Commun. 1985;17(9):831-9.
25. Zhu JX, Wang Y, Kong LD, Yang C, Zhang X. Effects of Biota
orientalis extract and its flavonoid constituents, quercetin and rutin
on serum uric acid levels in oxonate-induced mice and xanthine
dehydrogenase and xanthine oxidase activities in mouse liver. J
Ethnopharmacol. 2004;93(1):133-40.
26. Romero M, Jiménez R, Sánchez M, López-Sepúlveda R, Zarzuelo MJ,
O’Valle F, et al. Quercetin inhibits vascular superoxide production
induced by endothelin-1: Role of NADPH oxidase, uncoupled eNOS and PKC.
Atherosclerosis. 2009;202(1):58-67.
27. Boots AW, Haenen GR, Bast A. Health effects of quercetin: from
antioxidant to nutraceutical. Eur J Pharmacol. 2008;585(2-3):325-37.
28. Huk I, Brovkovych V, Nanobash Vili J, Weigel G, Neumayer C, Partyka
L, et al. Bioflavonoid quercetin scavenges superoxide and increases
nitric oxide concentration in ischaemia-reperfusion injury: an
experimental study. Br J Surg. 1998;85(8):1080-5.
29. Fanning MJ, Macander P, Drzewiecki G, Middleton E, Jr. Quercetin
inhibits anaphylactic contraction of guinea pig ileum smooth muscle. Int
Arch Allergy Appl Immunol. 1983;71(4):371-3.
30. Pearce FL, Befus AD, Bienenstock J. Mucosal mast cells. III. Effect
of quercetin and other flavonoids on antigen-induced histamine secretion
from rat intestinal mast cells. J Allergy Clin Immunol.
1984;73(6):819-23.
31. Bureau G, Longpré F, Martinoli MG. Resveratrol and quercetin, two
natural polyphenols, reduce apoptotic neuronal cell death induced by
neuroinflammation. J Neurosci Res. 2008;86(2):403-10.
32. Kumazawa Y, Kawaguchi K, Takimoto H. Immunomodulating effects of
flavonoids on acute and chronic inflammatory responses caused by tumor
necrosis factor alpha. Curr Pharm Des. 2006;12(32):4271-9.
33. Kimata M, Shichijo M, Miura T, Serizawa I, Inagaki N, Nagai H.
Effects of luteolin, quercetin and baicalein on immunoglobulin
E-mediated mediator release from human cultured mast cells. Clin Exp
Allergy. 2000;30(4):501-8.
34. Kempuraj D, Castellani ML, Petrarca C, Frydas S, Conti P,
Theoharides TC, et al. Inhibitory effect of quercetin on tryptase and
interleukin-6 release, and histidine decarboxylase mRNA transcription by
human mast cell-1 cell line. Clin Exp Med. 2006;6(4):150-6.
35. Shaik YB, Castellani ML, Perrella A, Conti F, Salini V, Tete S, et
al. Role of quercetin (a natural herbal compound) in allergy and
inflammation. J Biol Regul Homeost Agents. 2006;20(3-4):47-52.
36. Lines TC, Ono M. FRS 1000, an extract of red onion peel, strongly
inhibits phosphodiesterase 5A (PDE 5A). Phytomedicine. 2006;13(4):236-9.
37. Hubbard GP, Wolffram S, de Vos R, Bovy A, Gibbins JM, Lovegrove JA.
Ingestion of onion soup high in quercetin inhibits platelet aggregation
and essential components of the collagen-stimulated platelet activation
pathway in man: a pilot study. British Journal of Nutrition.
2006;96(3):482-8.
38. Pignatelli P, Di Santo S, Carnevale R, Violi F. The polyphenols
quercetin and catechin synergize in inhibiting platelet CD40L
expression. Thromb Haemost. 2005;94(4):888-9.
39. Fan PS, Gu ZL, Sheng R, Liang ZQ, Wang XX, Zhu Y. Inhibitory effect
of quercetin on proliferation of human microvascular endothelial cells
in vitro. Acta Pharmacol Sin. 2003;24(12):1231-4.
40. Kuznetsova T, Prange KHM, Glass CK, de Winther MPJ. Transcriptional
and epigenetic regulation of macrophages in atherosclerosis. Nat Rev
Cardiol. 2020;17(4):216-28.
41. Mendes LF, Gaspar VM, Conde TA, Mano JF, Duarte IF.
Flavonoid-mediated immunomodulation of human macrophages involves key
metabolites and metabolic pathways. Sci Rep. 2019;9(1):14906-.
42. Rodriguez-Mateos A, Vauzour D, Krueger CG, Shanmuganayagam D, Reed
J, Calani L, et al. Bioavailability, bioactivity and impact on health of
dietary flavonoids and related compounds: an update. Arch Toxicol.
2014;88(10):1803-53.